Insider · CIK 0001594274

Ordentlich Peter

Reports to the SEC for 1 company · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001594274

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-02-15	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+7,572 sh	$6.38	+$48.3K	7,572
2023-02-15	SNDXSyndax Pharmaceuticals IncS Sale	Chief Scientific Officer	SSale	−7,572 sh	$25.84	−$196K	0
2023-02-15	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+17.4K sh	$7.20	+$125K	17,428
2023-02-15	SNDXSyndax Pharmaceuticals IncS Sale	Chief Scientific Officer	SSale	−17.4K sh	$25.84	−$450K	0
2023-02-15	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−17.4K sh	$25.84	−$450K	0
2023-02-15	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−7,572 sh	$25.84	−$196K	0
2023-02-02	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)A Award	Chief Scientific Officer	AAward	+90K sh	$28.55	+$2.57M	90,000
2023-02-01	SNDXSyndax Pharmaceuticals IncS Sale	Chief Scientific Officer	SSale	−69 sh	$28.43	−$1,961.539	0
2023-01-31	SNDXSyndax Pharmaceuticals IncJ Other	Chief Scientific Officer	JOther	+69 sh	$17.32	+$1,195.08	69
2022-12-02	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+17.2K sh	$6.38	+$110K	17,465
2022-12-02	SNDXSyndax Pharmaceuticals IncS Sale	Chief Scientific Officer	SSale	−17.2K sh	$25.05	−$431K	265
2022-12-02	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−17.2K sh	—	—	0
2022-12-01	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,772 sh	$6.35	+$24K	4,037
2022-12-01	SNDXSyndax Pharmaceuticals IncS Sale	Chief Scientific Officer	SSale	−3,772 sh	$25.01	−$94.3K	265
2022-12-01	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+4,028 sh	$6.38	+$25.7K	4,293
2022-12-01	SNDXSyndax Pharmaceuticals IncS Sale	Chief Scientific Officer	SSale	−4,028 sh	$25.01	−$101K	265
2022-12-01	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−4,028 sh	—	—	0
2022-12-01	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,772 sh	—	—	0
2022-08-24	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+22.8K sh	$6.32	+$144K	23,111
2022-08-24	SNDXSyndax Pharmaceuticals IncS Sale	Chief Scientific Officer	SSale	−22.8K sh	$25.04	−$572K	265
2022-08-24	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,154 sh	$6.35	+$13.7K	2,419
2022-08-24	SNDXSyndax Pharmaceuticals IncS Sale	Chief Scientific Officer	SSale	−2,154 sh	$25.04	−$53.9K	265
2022-08-24	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,154 sh	—	—	0
2022-08-24	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−22.8K sh	—	—	0
2022-07-29	SNDXSyndax Pharmaceuticals IncJ Other	Chief Scientific Officer	JOther	+265 sh	$14.12	+$3,741.8	265
2022-02-02	SNDXSyndax Pharmaceuticals Inc · Stock Options (Right to buy)A Award	Chief Scientific Officer	AAward	+80K sh	$15.79	+$1.26M	80,000
2022-02-01	SNDXSyndax Pharmaceuticals IncS Sale	Chief Scientific Officer	SSale	−1,412 sh	$16.65	−$23.5K	0
2022-01-31	SNDXSyndax Pharmaceuticals IncJ Other	Chief Scientific Officer	JOther	+1,412 sh	$12.39	+$17.5K	1,412
2021-02-03	SNDXSyndax Pharmaceuticals Inc · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+80K sh	—	—	80,000
2020-11-23	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+24.3K sh	$3.08	+$74.8K	24,288
2020-11-23	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+5,684 sh	$3.08	+$17.5K	29,972
2020-11-23	SNDXSyndax Pharmaceuticals IncS Sale	Chief Scientific Officer	SSale	−5,684 sh	$23.33	−$133K	24,288
2020-11-23	SNDXSyndax Pharmaceuticals IncS Sale	Chief Scientific Officer	SSale	−7,954 sh	$23.58	−$188K	16,334
2020-11-23	SNDXSyndax Pharmaceuticals IncS Sale	Chief Scientific Officer	SSale	−16.3K sh	$22.89	−$374K	0
2020-11-23	SNDXSyndax Pharmaceuticals Inc · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−24.3K sh	—	—	0
2020-11-23	SNDXSyndax Pharmaceuticals Inc · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−5,684 sh	—	—	0
2020-02-12	SNDXSyndax Pharmaceuticals Inc · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+50K sh	—	—	50,000
2019-02-06	SNDXSyndax Pharmaceuticals Inc · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+80K sh	—	—	80,000
2018-04-03	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+7,500 sh	$3.08	+$23.1K	7,500
2018-04-03	SNDXSyndax Pharmaceuticals IncS Sale	Chief Scientific Officer	SSale	−7,500 sh	$15.00	−$113K	0
2018-04-03	SNDXSyndax Pharmaceuticals Inc · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−7,500 sh	—	—	0
2018-03-01	SNDXSyndax Pharmaceuticals Inc · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+40K sh	—	—	40,000
2017-05-17	SNDXSyndax Pharmaceuticals IncM Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+732 sh	$3.08	+$2,254.56	5,000
2017-05-17	SNDXSyndax Pharmaceuticals IncS Sale	Chief Scientific Officer	SSale	−5,000 sh	$15.00	−$75K	0
2017-05-17	SNDXSyndax Pharmaceuticals Inc · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−732 sh	—	—	0
2017-02-06	SNDXSyndax Pharmaceuticals Inc · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+20K sh	—	—	20,000

Recent filings

Accepted (ET)
Feb 174
Ordentlich Peter0001562180-23-001533
SEC(opens sec.gov)
Feb 34
Ordentlich Peter0001562180-23-000950
SEC(opens sec.gov)
Dec 24
Ordentlich Peter0001562180-22-008017
SEC(opens sec.gov)
Aug 264
Ordentlich Peter0001562180-22-006334
SEC(opens sec.gov)

Companies

Syndax Pharmaceuticals IncChief Scientific OfficerSNDX

Address

C/O SYNDAX PHARMACEUTICALS, INC. 400 TOTTEN POND ROAD, SUITE 110

WALTHAM, MA, 02451